Eyenovia, Inc. (NASDAQ:EYEN) Q1 2024 Results Conference Call May 14, 2024 4:30 PM ET
Company Participants
Eric Ribner - IR
Michael Rowe - Chief Executive Officer
John Gandolfo - Chief Financial Officer
Bren Kern - Chief Operating Officer
Conference Call Participants
Matt Kaplan - Ladenburg
Matthew Caufield - H.C. Wainwright
Kemp Dolliver - Brookline Capital Markets
Operator
Good afternoon, ladies and gentlemen, and welcome to the Eyenovia First Quarter 2024 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator instructions] This call is being recorded.
I would now like to turn the conference over to Mr. Eric Ribner of Investor Relations. Please go ahead.
Eric Ribner
Good afternoon, and welcome to Eyenovia's first quarter 2024 earnings conference call and audio webcast. With me today are Eyenovia's Chief Executive Officer, Michael Rowe, Chief Financial Officer, John Gandolfo; and Chief Operating Officer, Bren Kern.
This afternoon, we issued a press release announcing financial results for the three months ended March 31, 2024. We encourage everyone to read today's press release as well as Eyenovia's quarterly report on Form 10-Q for the quarter March 31, 2024, which will be filed with the SEC tomorrow.
The company's press release is available on our website at eyenovia.com. In addition, this conference call is being webcast to the company's website and will be archived there for future reference. Please note that on today's call, we will be discussing products, product concepts and candidates, some of which have yet to receive FDA approval.
Please also note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during the call, Eyenovia's management will make forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business.
These forward-looking statements are subject to a number of risks, which are described in more detail on our annual report on Form 10-K. The conference call contains time-sensitive information that is accurate only as of the date of this live broadcast, May 15, 2024. Eyenovia undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call, except as maybe required by the applicable securities laws.
With that said, I'd like to turn the call over to Michael Rowe, Eyenovia's Chief Executive Officer. Michael?